General MedicationsORALGeneric

PHENTERMINE RESIN COMPLEX

Standard Dose

EQ 15MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview PHENTERMINE RESIN COMPLEX is listed in Drugs@FDA under application 040872 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PHENTERMINE RESIN COMPLEX Form and strength CAPSULE, EXTENDED RELEASE;ORAL - EQ 15MG BASE Sponsor LANNETT CO INC Submission history Latest submission status date: 2017-05-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview PHENTERMINE RESIN COMPLEX is listed in Drugs@FDA under application 040872 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PHENTERMINE RESIN COMPLEX Form and strength CAPSULE, EXTENDED RELEASE;ORAL - EQ 15MG BASE Sponsor LANNETT CO INC Submission history Latest submission status date: 2017-05-31 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.